European Primary Care Cardiovascular Society

Improved outcomes with SGLT2i in HFpEF and HFmrEF

3' education - Aug. 27, 2022 - Prof. Scott Solomon, MD - Boston, MA, USA

Educational information

This video was recorded during the ESC Congress 2022 in Barcelona, Spain.


Scott D. Solomon, MD is the Edward D. Frohlich Distinguished Chair, Professor of Medicine at Harvard Medical School and directs the Clinical Trials Outcomes Center at Brigham and Women’s Hospital.


This recording was developed under auspices of EPCCS. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of EPCCS.

Read our summary of the DELIVER trial

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: